Humacyte Statistics
Share Statistics
Humacyte has 155.12M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding | 155.12M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Institutions (%) | n/a |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 44 |
FTD / Avg. Volume | 0.14% |
Short Selling Information
Short Interest | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Valuation Ratios
PE Ratio | 0 |
Forward PE | n/a |
PS Ratio | 0 |
Forward PS | 0.5 |
PB Ratio | -11.36 |
P/FCF Ratio | -6 |
PEG Ratio | 0 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Humacyte.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.4,
with a Debt / Equity ratio of -0.31.
Current Ratio | 2.4 |
Quick Ratio | 2.4 |
Debt / Equity | -0.31 |
Debt / EBITDA | -0.14 |
Debt / FCF | -0.17 |
Interest Coverage | 12.33 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | 218 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -50.67% in the
last 52 weeks. The beta is 1.62, so Humacyte's
price volatility has been higher than the market average.
Beta | 1.62 |
52-Week Price Change | -50.67% |
50-Day Moving Average | 0.66 |
200-Day Moving Average | 1.58 |
Relative Strength Index (RSI) | 40.98 |
Average Volume (20 Days) | 31,703 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -114.4M |
Net Income | n/a |
EBITDA | -114.4M |
EBIT | n/a |
Earnings Per Share (EPS) | -1.26 |
Full Income Statement Balance Sheet
The company has 44.94M in cash and 16.54M in
debt, giving a net cash position of 28.4M.
Cash & Cash Equivalents | 44.94M |
Total Debt | 16.54M |
Net Cash | 28.4M |
Retained Earnings | -686.01M |
Total Assets | 137.87M |
Working Capital | 27.91M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -98.12M
and capital expenditures -1.57M, giving a free cash flow of -99.69M.
Operating Cash Flow | -98.12M |
Capital Expenditures | -1.57M |
Free Cash Flow | -99.69M |
FCF Per Share | -0.84 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |